NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Quick Ratio in % from Q1 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Quick Ratio history and growth rate from Q1 2022 to Q3 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Quick Ratio for the quarter ending September 30, 2024 was 108 %, a 30% increase year-over-year.
Quick Ratio, Quarterly (%)
Quick Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 108 +24.8 +30% Sep 30, 2024
Q2 2024 101 +44.9 +80.8% Jun 30, 2024
Q1 2024 95.4 +47.7 +100% Mar 31, 2024
Q4 2023 93.1 +55.4 +147% Dec 31, 2023
Q3 2023 82.8 +55 +198% Sep 30, 2023
Q2 2023 55.6 +29.7 +114% Jun 30, 2023
Q1 2023 47.6 +31.8 +201% Mar 31, 2023
Q4 2022 37.7 Dec 31, 2022
Q3 2022 27.8 Sep 30, 2022
Q2 2022 25.9 Jun 30, 2022
Q1 2022 15.8 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.